Food compositions for feline atopic dermatitis
A food composition with a specific EPA:DHA ratio effectively addresses the adverse effects of current treatments for feline atopic dermatitis by reducing symptoms and dependency on chemical medications, offering a safe and edible solution.
Patent Information
- Application Number
- PCT/US2026/027375
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-19
AI Technical Summary
Current therapeutic approaches for feline atopic dermatitis, such as pharmacological medications, are associated with adverse effects and there is a need for safe, edible, and effective non-chemical alternatives to manage, treat, and prevent this chronic inflammatory allergic skin disorder.
A food composition enriched with a specific EPA:DHA mass ratio, optionally including curcuminoids, designed to reduce the severity of feline atopic dermatitis by improving clinical scores and reducing symptoms like skin lesions and pruritus.
The EPA:DHA food composition significantly reduces the severity of feline atopic dermatitis symptoms and decreases the need for chronic anti-feline atopic dermatitis medications, improving the quality of life for affected felines.
Abstract
Description
Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 FOOD COMPOSITIONS FOR FELINE ATOPIC DERMATITISCROSS-REFERENCE TO RELATED APPLICATION(S)
[0001] This patent application claims the benefit of priority to European Patent Application No. EP 25176164.9, filed on May 13, 2025, the entirety of which is incorporated herein by reference.FIELD OF THE DISCLOSURE
[0002] The present disclosure relates to the field of feline food compositions. In particular, the present disclosure relates to food compositions and methods for preventing and / or treating feline atopic dermatitis in felines, in particular cats.BACKGROUND OF THE DISCLOSURE
[0003] Feline atopic dermatitis is a significant chronic inflammatory allergic skin disorder affecting felines having a hypersensitivity to environmental allergens. This disorder is often associated with pruritus and erythema. Clinically, it is characterized by diverse dermatological patterns, including pruritus (especially of the head and neck), miliary dermatitis, eosinophilic plaques and granulomas, or overgrooming behaviors often leading to alopecia and skin barrier damage. In some cases, respiratory signs such as coughing, sneezing, or wheezing may also be observed.
[0004] The heritable aspects of atopic dermatitis is currently insufficiently characterized in felines. It is believed to result from a complex interaction between genetic predisposition, environmental allergens, skin barrier dysfunction, and immune dysregulation. Nevertheless, the evidence substantiating these mechanisms in felines is comparatively limited relative to canines and humans. Notably, there has been some lack of consensus regarding the role of immunoglobulin (lg)E in the development of hypersensitivity to environmental allergens (formerly atopic dermatitis), whereas the role of this antibody is more evident in atopic dermatitis in dogs and humans. Feline atopic dermatitis, also referred to as Feline Atopic Skin Syndrome (FASS), presents with a broader spectrum of clinical signs compared to canine atopic dermatitis, typically manifesting according to one or more of four different clinical lesion patterns: miliary dermatitis, self-induced alopecia, head and neck pruritus, and eosinophilic granuloma complex. In contrast, canine atopic dermatitis presents with a more limited range and distribution of clinical signs. Consequently, feline atopic dermatitis is considered as a distinct disorder, rather than a direct analogue of the canine atopic dermatitis, necessitating a specific diagnostic and therapeutic considerations.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0005] WO2017058291 discloses pet food compositions designed for managing non-food allergies specifically in dogs. EP0987961 discloses food compositions including zinc and linoleic acid for improving skin and coat condition in healthy animals. However, these food compositions are not effective for managing or treating feline atopic dermatitis.
[0006] Current therapeutic approaches primarily focus on pharmacological medications such as ciclosporin, corticosteroids, antihistamines, or immunomodulators. While often effective in reducing symptoms, these approaches can be associated with adverse effects when used chronically, such as vomiting, diarrhea, or immunosuppression.
[0007] There is thus a growing need for alternative options for managing, treating, preventing and / or reducing the severity of feline atopic dermatitis and / or symptoms thereof.
[0008] In particular, there is a need for non-chemical medications that can be safe, edible, and effective over the long term for managing, treating, preventing and / or reducing the seventy of feline atopic dermatitis.
[0009] There is a need for alternative non-chemical medications that can contribute to prevent or treat feline atopic dermatitis.
[0010] There is also a need for alternative non-chemical medications for managing and / or reducing symptoms of feline atopic dermatitis, particularly to alleviate pain, to reduce the severity of skin inflammation, to reduce the severity of pruritus, to reduce the frequence of scratch, and improve the overall well-being of felines.
[0011] There is also a need for novel solutions that can reduce the need or dependence of felines to anti-feline atopic dermatitis chemical medications.
[0012] The present disclosure has for purpose to satisfy all or part of the above-mentioned needs.SUMMARY OF THE DISCLOSURE
[0013] The present disclosure addresses all or part of the above-mentioned needs by providing a food composition including a particular EPA:DHA mass ratio, which has been designed to prevent, treat or reduce the severity of feline atopic dermatitis or symptoms thereof in a feline.
[0014] Thus, a first aspect of the present disclosure relates to a food composition including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 for use in a method for managing, treating and / or preventing feline atopic dermatitis in a feline in need thereof, whereinthe mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3: 1 to about 0.9:1, andthe total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal.
[0015] This food composition described herein offers the advantage of significantly improving the reduction of the severity of skin lesions, inflammation and pruritus in felines affected with feline atopic dermatitis. The food composition described herein enriched with DHA and EPA, and optionally curcuminoids, significantly improves the clinical scores associated with feline atopic dermatitis (FeDESI, VAScat, and Medication scores) of a feline compared to a standard feline food composition that does not include a ratio of EPA: DHA from about 0.2:1 to about 1:1.
[0016] In particular, a further advantage of the food composition described herein can rely in its capacity to reduce the symptoms of feline atopic dermatitis, such as skin lesions, inflammation and / or pruritus on the feline’s body.
[0017] A further advantage of the food composition described herein can rely in its capacity to decrease the need of chronic anti-feline atopic dermatitis medications for treating or reducing the severity of feline atopic dermatitis symptoms.
[0018] A further advantage of the food composition described herein can rely in its capacity to improving the quality of life in felines affected with feline atopic dermatitis.
[0019] In some embodiments, the food composition described herein can comprise curcuminoids, in particular from about 0.1 g / Mcal to about 2 g / Mcal of curcuminoids.
[0020] In some embodiments, the curcuminoids can be selected from curcumin, demethoxycurcumin, bisdemethoxycurcumin and / or tetrahydrocurcumin.
[0021] In some embodiments, the food composition described herein can comprise from about 0.05 g / Mcal to about 10 g / Mcal of EPA.
[0022] In some embodiments, the food composition described herein can comprise from about 0.05 g / Mcal to about 20 g / Mcal of DHA.
[0023] In some embodiments, the food composition described herein can comprise a total amount from about 0.5 g / Mcal to about 10 g / Mcal of EPA and DHA.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0024] In some embodiments, a source of the EPA and the DHA, introduced in the food composition described herein, can be selected from fish oil, fish meal, algae oil, eggs, oyster, chia seed, walnuts, soybeans, Green Leaped Mussel or a mixture thereof.
[0025] In some embodiments, the food composition described herein can further comprise linoleic acid, Taurine, Lutein, Vitamin E, or combinations thereof.
[0026] In some embodiments, the food composition described herein can further comprise at least one of:
[0027] from about 4.5 g / Mcal to about 23 g / Mcal of linoleic acid;
[0028] from about 0.2 g / Mcal to about 5 g / Mcal of Taurine;
[0029] from about 0.002 g / Mcal to about 0.015 g / Mcal of Lutein;
[0030] from about 0.1 g / Mcal to about 1.5 g / Mcal of Vitamin E;
[0031] or combinations thereof.
[0032] In some embodiments, the food composition described herein does not comprise glycyrrhizin.
[0033] In some embodiments, the food composition described herein can be a nutritionally complete and balanced food composition.
[0034] In some embodiments, the feline atopic dermatitis can be an environmental allergen-induced atopic dermatitis.
[0035] In some embodiments, the feline atopic dermatitis can be a feline atopic skin syndrome.
[0036] In some embodiments, the food composition can be provided to the feline during, before and / or after a treatment with an anti-feline atopic dermatitis agent, optionally for a period of between about one month to about thirty-six months. In some embodiments, the food composition can be provided to the feline during a treatment with an anti-feline atopic dermatitis agent, optionally for a period of between about one month to about thirty-six months.
[0037] In some embodiments, the feline can be a cat.BRIEF DESCRIPTION OF THE FIGURES
[0038] Figure 1 depicts a graph illustrating the evolution of the VAS-cat score in two groups of cats fed with the test or control food composition. The mean observed score (95% confidence interval) were observed at the baseline (before treatment), Month 3 and End point (6 months).Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0039] Figure 2 depicts a graph illustrating the evolution of the FeDESI score in two groups of cats fed with the test or control food composition. The mean observed score (95% confidence interval) were observed at the baseline (before treatment), Month 3 and End point (6 months).
[0040] Figure 3 depicts a graph illustrating the evolution of the Medication score in two groups of cats fed with the test or control food composition. The mean observed score (95% confidence interval) were observed at the baseline (before treatment), Months 1-2, Months 3, Months 4, Months 5 and End point (6 months).DETAILED DESCRIPTION OF THE DISCLOSURE
[0041] The present disclosure provides a feline food composition including a particular EPA:DHA mass ratio, which has been designed to treat and / or prevent feline atopic dermatitis in a feline in need thereof. This feline food composition described herein offers the advantage of improving the reduction of the seventy of feline atopic dermatitis and symptoms thereof, and / or reducing the need for the feline’s owners to use chronic anti-feline atopic dermatitis agent to treat their felines in need thereof.Definitions
[0042] The terms used in this disclosure generally have their ordinary meanings in the art, within the context of this disclosure and in the specific context where each term is used. Certain terms are discussed below, or elsewhere in the specification, to provide additional guidance in describing the compositions and methods of the disclosure and how to make and use them.
[0043] Exemplary methods and food compositions are described below, although methods and food compositions similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure. Further, unless otherwise required by context, singular terms shall include pluralities and plural terms shall include the singular.
[0044] Numeric ranges are inclusive of the numbers defining the range. The headings provided herein are not limitations of the various aspects of the disclosure. Accordingly, the terms defined immediately below are more fully defined by reference to the specification in its entirety.
[0045] All publications and other references mentioned herein are incorporated by reference in their entirety.
[0046] As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictatesAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 otherwise. The terms "a" (or "an"), as well as the terms "one or more," and "at least one" can be used interchangeably herein. In some aspects, the term "a" or "an" means "single." In other aspects, the term "a" or "an" includes "two or more" or "multiple." Thus, for example, reference to “a source of an ingredient” can include a mixture of at least two sources of an ingredient.
[0047] As used herein, "and / or" is to be taken as specific disclosure of each of the two specified features or components with or without the other. Thus, the term "and / or" as used in a phrase such as "A and / or B" herein is intended to include "A and B," "A or B," "A" (alone), and "B" (alone). Likewise, the term "and / or" as used in a phrase such as "A, B, and / or C" is intended to encompass each of the following aspects: A, B, and C; A, B, or C; A or C; A or B; B or C; A and C; A and B; B and C; A (alone); B (alone); and C (alone).
[0048] The term “about”, as used herein, means within an acceptable error range for the particular value as determined by one of ordinary skill in the art, which will depend in part on how the value is measured or determined, i.e., the limitations of the measurement system. In general, the term “about” can modify a numerical value above and below the stated value by a variance of, for instance, 10 percent, up or down (higher or lower). In some embodiments, the term indicates deviation from the indicated numerical value by ±15%, ±10%, ±5%, ±4%, ±3%, ±2%, or ±1%.
[0049] As used herein, the terms “comprise”, “comprising”, “include”, “including” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a food composition, a process or a method that includes or comprises a list of nutriments, ingredients, or steps which does not include only those nutriments, ingredients, or steps but can include other nutriments, ingredients, or steps not expressly listed or inherent to such food composition, process or method. The term “consisting of’ implies the inclusion of the stated element(s), to the exclusion of any additional nutriments, ingredients, or steps. The term “consisting essentially of” implies the inclusion of the stated elements, and possibly other element(s) where the other element(s) do not materially affect the basic and novel characteristic(s) of the disclosure. It is understood that the different embodiments of the disclosure using the term “including” or equivalent cover the embodiments where this term is replaced with “consisting of” or “consisting essentially of”.
[0050] In the detailed description herein, references to “embodiment,” “an embodiment,” “one embodiment,” “in some embodiments,” or any other variationAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 thereof, indicate that the described embodiment(s) can include a particular nutriments, ingredients, or steps, but every embodiment might not necessarily include the particular nutriments, ingredients, or steps. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular nutriments, ingredients, or steps is described in connection with an embodiment, it is submitted that it is within the knowledge of one skilled in the art to affect such nutriments, ingredients, or steps in connection with other embodiments whether or not explicitly described. After reading the description, it will be apparent to one skilled in the relevant art(s) how to implement the disclosure in alternative embodiments.
[0051] As used herein, the term “feline” refers to any animal of the taxonomic family Felidae, characterized by shared physical traits including a compact body, retractable claws, sharp carnivorous teeth, keen senses (particularly vision and hearing), and a flexible muscular structure that enables agility and swift movements. Felines can encompass a diverse range of species, such as cats, like wild cats and domestic cats, lions, tigers, leopards, jaguars, and other big wild cats. In some embodiments, a feline can be a cat, in particular a domestic cat.
[0052] As used herein, the term “food composition” covers all of foodstuff, diet, food supplement or a material that can sustain growth, repair and vital processes of a cat. Such a food composition can contain one or more ingredients, such as source of nutriments. Nutriments of a food composition can be typically proteins, fibers, carbohydrates and / or fats, which can be used in combination in the body of an organism to sustain growth, repair and vital processes and to furnish energy (defined with the metabolizable energy (ME)). A food composition as disclosed herein can also contain supplementary ingredients such as substances or additives, for example, flavoring, minerals and vitamins. A food composition as disclosed herein can further contain a carrier, a diluent, and / or an excipient.
[0053] As used herein, “nutritionally complete and balanced” in the context of a food composition means that the food composition comprises all the essential nutrients in appropriate proportions to meet an animal's dietary requirements for maintaining overall health and well-being. A nutritionally complete and balanced food composition can maintain the body weight of the cat without significant change with the Body Condition Score (BCS). A nutritionally complete and balanced food composition ensures that the animal receives all the necessary nutrients for optimal health, minimizing the risk of nutritional deficiencies or imbalances that could lead toAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 health issues over time. Specifically, a nutritionally complete and balanced food composition can contain all known required nutrients for the intended recipient of the food composition, in all appropriate amounts and proportions based, for example, on recommendations of recognized and competent authorities in the field of feline or canine nutrition, such as the Association of American Feed Control Officials (AAFCO) or the European Pet Food Industry Federation (FEDIAF), for complete and balanced pet nutrition. Therefore, a nutritionally adequate diet is a diet with which said animal can be fed as the sole ration and is capable of sustaining life without additional food (except water). For instance, a nutritionally complete and balanced food composition can contain carbohydrates, proteins, fats, vitamins and minerals, and optionally water.
[0054] As used herein, the term “functional complement” refers to a food composition which provides nutritional components that are important for health maintenance. These food compositions contain compounds that are biologically active or bioavailable, such as probiotics, amino acids, multivitamins, and antioxidants, and often are found to be useful for the treatment of disease and disorders or the maintenance of normal health states. Functional complements are not nutritionally complete food compositions, meaning that a functional complement does not provide the complete and balanced nutritional requirements to a feline. Functional complements are generally used in conjunction with another feed to improve the nutritive balance or performance of the total feed and intended to be fed undiluted as an addition to other feeds. As non-limitative examples, it can be mentioned chews, soft chews, tablets, powder, liquid, jelly, etc. The person skilled in the art is well aware of how to prepare a functional complement. As non-limitative example for jellies, it can be mentioned the following products: Vitakraft Jelly Lovers, Premiere by Fressnapf, Vetocanis Agrobiothers laboratoire, Vital Veto, Laboratoire francodex friandise humides.
[0055] As used herein, the term “anti-feline atopic dermatitis agent” or “antifeline atopic dermatitis medication” refers to any substance or composition used to treat, specifically to reduce the severity, of feline atopic dermatitis also referred as Feline Atopic Skin Syndrome (FASS). Generally, an anti-feline atopic dermatitis agent can be an oral or a topical treatment and is chronically used, specifically on several days, weeks or months. For instance, an anti-feline atopic dermatitis agent can be antihistamines, immunomodulators, ciclosporin or corticosteroids.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0056] In the context of the present disclosure, an "ingredient" or “component” refers to any individual component or substance that is intentionally included in the formulation of a food composition. An ingredient can be of various types, such as a source of proteins, a source of carbohydrates, a source of fats, a source of vitamins, a source of minerals, flavorings, preservatives, and / or other additives. An ingredient can be a raw material, a raw material by-product, an additive and / or a nutritional supplement. The selection and combination of ingredients can be critical in producing a complete and balanced food composition for a feline.
[0057] As used herein “eicosapentaenoic acid” or “EPA” refers to a polyunsaturated fatty acid belonging to the omega-3 family. Chemically, it is a 20-carbon chain with 5 double bonds. The CAS Registry Number® of EPA is 10417-94-4.
[0058] As used herein “docosahexaenoic acid” or “DHA” refers to a polyunsaturated fatty acid belonging to the omega-3 family. Chemically, it is 22 carbon atoms and 6 double bonds, chemically identified as C22:6. The CAS Registry Number® of DHA is 6217-54-5.
[0059] As used herein, the term “curcuminoids” refers to phenols that are primarily found in turmeric, a plant belonging to the ginger family. Turmeric is generally derived from the roots of the plant Curcuma longa. Curcuminoids have also been found in roots of other species in the plant family Zingiberaceae of the Curcuma genus. Curcuminoids can include curcumin, demethoxycurcumin, bisdemethoxycurcumin and / or tetrahydrocurcumin. The chemical structures of curcuminoids differ in their functional groups. In particular, turmeric can contain about 60% to about 80% of curcumin, about 15% to about 30% of demethoxycurcumin and about 2% to about 6% of bisdemethoxycurcumin. Curcuminoids can be found in some naturally-occuring extracts and / or plants, or chemically obtained. A source of curcuminoids can consist of a turmeric extract, i.e., Curcuma Longa. Non-limitative examples of turmeric extract are the turmeric extract BCM-95® from Arjuna or the turmeric extract from Naturex. Any other source of curcuminoids known to a person skilled in the art can also be used. Curcuminoids can be found in other botanicals in addition to Curcuma longa, such as Curcuma xanthorrhiza and Curcuma zedoania. Curcuminoid in its pure form has poor solubility in water. Curcuminoids can be extracted from curcuminoids-containing plants, e.g., turmeric root, with organic solvent such as ethanol or acetone.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0060] As used herein, the term “lutein” refers to a xanthophyll and one of known naturally occurring carotenoids. Lutein is a lipophilic molecule and is generally insoluble in water. Lutein is synthesized only by plants and like other xanthophylls is found in high quantities in green leafy vegetables such as spinach, kale and yellow carrots. Lutein is isomeric with zeaxanthin, differing only in the placement of one double bond. The principal natural stereoisomer of lutein is (3R,3'R,6'R)-beta, epsilon-carotene-3,3'-diol. Lutein is present in plants as fatty-acid esters, with one or two fatty acids bound to the two hydroxyl-groups.
[0061] As used herein, the term “linoleic acid” refers to a polyunsaturated omega-6 fatty acid, (9Z,12Z)-octadeca-9,12-dienoic acid, which is one of two essential fatty acids for animals. For measuring the content of a food composition in linoleic acid, the one skilled in the art can refer to any of well-known techniques. For example, a method based upon the norm NF EN ISO 5508 / 5509 via chromatography in gaseous phase can be used. Linoleic sources, i.e., linoleic acid-containing substances, can include safflower oil, sunflower oil, soybean oil, sesame oil, canola oil, other plant or animal oils / crude fats, meats or a combination of two or more thereof.
[0062] As used herein, the term “Taurine” refers to an organic compound classified as a beta-amino sulfonic acid. Taurine is a non-essential amino acid which is obtained from meat and fish. Taurine refers to a compound of the molecular formula C2H7NO3S.
[0063] As used herein, the term “Vitamin E” refers to a collective term for a group of fat-soluble compounds with antioxidant properties, including those called tocopherols and tocotrienols, which share the same biological activity. The most biologically active biological form of Vitamin E (also the most active antioxidant) in animal tissue is alpha-tocopherol. Vitamin E cannot be synthesized in vivo. Vitamin E protects against the loss of cell membrane integrity, which adversely alters cellular and organelle function. Vitamin E can be in any form. In some embodiments, Vitamin E can be liquid, semi-solid or solid. In some embodiments, Vitamin E can be a tocopherol or a tocotrienol. In some embodiments, Vitamin E can be alphatocopherol, (d-x or dl-oc) beta-tocopherol (d-,B or dl-), gamma-tocopherol (dot or dim), delta-tocopherol, alpha-tocotrienol, beta-tocotrienol, gamma-tocotrienol or delta-tocotrienol. In some embodiments, Vitamin E is alpha-tocopherol. A source of Vitamin E is not limiting. In certain embodiments, a Vitamin E source can include Vitamin E acetate,Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 (e.g., tocopherol acetate), Vitamin E acetate adsorbate or Vitamin E acetate spray dried. In some embodiments, a source of Vitamin E can be synthetic or natural.
[0064] As used herein the term “providing” includes selling, supplying, administering, or feeding a feline.
[0065] As used herein, the term “weight percent” or “wt%” or “by weight” is meant to refer to the quantity by weight of a nutrient or ingredient in a food composition as a percentage on a dry matter basis of the food composition, unless otherwise specified. The specified amount of nutrients or ingredients included in a food composition described herein represents the amount present in the total quantity of raw materials provided as sources of said nutriments or ingredients for producing the said food composition.
[0066] The expression “dry matter basis” or “DM” must be interpreted as a method of expressing the concentration of a nutrient or an ingredient in a food composition by expressing its concentration relative to its dry matter content (the concentration remaining once the moisture has been taken out). At the opposite, the expression “as fed” must be interpreted as a method of expressing the concentration of a nutrient or an ingredient in a food composition by expressing its concentration in the state it is fed, which includes moisture. It is appreciated that certain features of the disclosure, which are, for clarity, described in the context of separate embodiments, can also be provided in combination in a single embodiment. Conversely, various features of the disclosure, which are, for brevity, described in the context of a single embodiment, can also be provided separately or in any suitable sub-combination.
[0067] As used herein, the expression “feline atopic dermatitis”, also named “Feline Atopic Skin Syndrome” or “FASS”, refers to a chronic allergic skin disease in felines, specifically in cats. Feline atopic dermatitis encompasses a variety of skin reactions in felines that are generally caused by allergies to environmental allergens, such as: pollens, insects, dust mites, and / or molds. Feline atopic dermatitis can be clinically characterized by one or more of the following cutaneous reaction patterns: Miliary dermatitis, self-induced alopecia, pruritus (face, head and / or neck), and eosinophilic dermatoses (plaques, granulomas, ulcers). Diagnosis of feline atopic dermatitis relies on clinical evaluation including (a) evaluation of the presence of the one or more of the above defined cutaneous reaction patterns and (b) exclusion of other diseases with similar clinical characteristics. The other diseases with similar clinical characteristics to be excluded includes fleas / flea allergy, other parasites (suchAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 as Demodex mites, Notoedres, Cheyletiella, Otodectes, trombiculid mites, and Lynxacarus), infections, and food allergy. Seventy assessment of feline atopic dermatitis associated with the four main patterns can be typically conducted using clinical scoring methods such as the Feline Dermatitis Extent and Seventy Index (FeDESI) and the Dual feline pruritus Visual Analog Scale (VAScat). These methods evaluate the seventy of erythema, excoriations / erosions, and self-induced alopecia (Santoro et al. (2021)). In some embodiments, feline atopic dermatitis is feline atopic skin syndrome. Feline atopic dermatitis, specifically feline atopic skin syndrome, can be diagnosed based on guidelines established by Santoro et al. (2021).
[0068] As used herein, the terms “treating” or “treatment” in the present disclosure refers to the administration of a food composition according to the disclosure with the purpose to treat, alleviate, relieve, alter, remedy, ameliorate, improve, or affect feline atopic dermatitis, the symptoms of feline atopic dermatitis, the likelihood of feline atopic dermatitis, or to prevent or delay the onset of the symptoms, complications, or otherwise arrest or inhibit further development of feline atopic dermatitis in a statistically significant manner in a feline. Beneficial or desired clinical results can encompass, but are not limited to, alleviation or amelioration of one or more symptoms or conditions associated with feline atopic dermatitis; diminishment or reduction of the severity of feline atopic dermatitis or symptoms related to feline atopic dermatitis; maintaining the stability (preventing deterioration) of feline atopic dermatitis; delaying or slowing down the progression of feline atopic dermatitis; minimizing the recurrence of feline atopic dermatitis; and remission, whether partial or total and whether detectable or undetectable. In other words, “treatment” as used herein includes any cure, amelioration, or reduction of the severity of feline atopic dermatitis. A “reduction” of the severity of feline atopic dermatitis means decreasing of the severity or frequency of feline atopic dermatitis or one or more symptoms thereof, or elimination of feline atopic dermatitis or one or more symptoms thereof. Symptoms of feline atopic dermatitis can include, but is not limited to, skin lesions (e.g. several small papules), pruritus, hair loss, erythema, alopecia, crusts, excoriation, apparition of eosinophilic granuloma, and / or apparition of eosinophilic plaque.
[0069] As used herein, the terms “prevent” or “preventing” with respect to feline atopic dermatitis relate to prophylactic treatment of a feline suspected to have feline atopic dermatitis, or at risk for developing feline atopic dermatitis. Prevention may include, but is not limited to, preventing, or delaying onset or progression of felineAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 atopic dermatitis and / or maintaining one or more symptoms of feline atopic dermatitis at a desired or sub-pathological level. The term “prevent” does not require the 100% elimination of the possibility or likelihood of occurrence of the event. Rather, it denotes that the likelihood of the occurrence of the event has been reduced in the presence of a composition or method described herein. More particular, “prevent” or “preventing” refers to a decrease in the risk of occurrence of feline atopic dermatitis or symptoms thereof in a feline. As indicated above, the prevention may be complete, i.e., no detectable symptoms or disease, or partial, such that fewer symptoms or less severity of feline atopic dermatitis are observed than would likely occur absent treatment.
[0070] As used herein, the term “Feline Dermatitis Extent and Severity Index” or “FeDESI” refers to a scoring system to evaluate the extent and severity of dermatitis in felines. The FeDESI assesses the severity of skin inflammation by quantifying clinical signs and their extent on the feline's body (e.g., head, neck, trunk, limbs). Each affected area is scored based on the severity of lesions, including signs like erythema (redness), excoriation (scratching), lichenification (thickening of the skin), and / or alopecia (hair loss). The total score is calculated by combining the extent and severity scores, providing a tool to assess the likelihood that a feline has dermatitis.
[0071] As used herein, “Visual Analog Scale for feline pruritus severity scoring” or “VAS-cat” refers to a scoring system used to assess the severity of itching (pruritus) in felines. This score is comprising a linear scale ranging from 'no pruritus' to 'severe pruritus', wherein the scale is used by a veterinary professional or caretaker to visually indicate the degree of pruritus experienced by the feline.
[0072] As used herein, the term “Medication score” refers to a quantitative system designed to measure the frequency and dosage of one or more medicinal agent administered by an animal to control a disorder or disease. The scoring system has been described previously (Saridomichelakis et al. Vet Rec 2021; 188: e19) with a higher score corresponding to a higher medication burden for the animal.
[0073] It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrowerAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
[0074] All lists of items, such as, for example, lists of ingredients, are intended to and should be interpreted as Markush groups. Thus, all lists can be read and interpreted as items “selected from the group consisting of’ the list of items “and combinations and mixtures thereof.”Units
[0075] As used herein, an amount of a nutrient or an ingredient as expressed as weight per megacalories, such as grams per megacalorie (g / Mcal), consists of a weight amount of the said nutrient or ingredient by unit of Metabolizable Energy (ME) of the food composition.
[0076] As used herein, the ME parameter is intended to represent the energy value of a food composition that is directly metabolized after consumption. Within the scope of the present disclosure, the ME value can be measured by any suitable method known in the art.
[0077] Illustratively, the ME value can be measured using feeding trial. In practice, the gross energy (GE) of the food composition is determined in the laboratory, and the amounts of food eaten by the animals are recorded. The feces and urine from the animals are collected, and the energy in each is determined and called fecal energy (FE) and urinary energy (UE), respectively. The ME is then calculated as:ME (kcal / kg) = [GE - (FE + UE)] / Kg of food consumed.
[0078] Alternatively, the ME value can be measured by standard mathematical methods, taking into account, depending on the method, the percentage of crude fat (CF), of crude protein (CP), of NFE (carbohydrates) and / or of Total Dietary Fibers (TDF) in the food composition. In practice each percentage is multiplied by its respective Atwater Factors. The resulting sum is then multiplied by 10. The mathematical method can be represented by the following formula:ME (kcal / kg) = 10 x [(3.5 x CP) + (8.5 x CF) + (3.5 x NFE)].
[0079] In some embodiments, the ME can be determined according to the predictive equation proposed by the National Research Council (NRC) in 2006.
[0080] In a particular embodiment of the disclosure, especially for a cat, the ME, in kcal / 100g, can be calculated as:ME = GE x [95.6 - (0.89 x TDF x 100 / DM) ] / 100) - (0.77 x CP) orAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 ME = GE x [87.9 - (0.88 x CF x 100 / DM) ] / 100) - (0.77 x CP) with GE = (5.7 x CP) + (9.4 x CF) + [4.1 x (NFE + CF)]
[0081] In some embodiments, a food composition as disclosed herein can be characterized by its Metabolizable Energy (ME) parameter.
[0082] In some embodiments, a food composition as disclosed herein can be a dry food composition having a Metabolizable Energy (ME) of at least about 2500 kilocalories per kilogram, as measured according to the NRC 2006.
[0083] In some embodiments, a food composition as disclosed herein can be a wet food composition having a Metabolizable Energy (ME) of at least about 400 kilocalories per kilogram, as measured according to the NRC 2006.
[0084] In some embodiments, a food composition described herein can be a dry food composition, typically having a moisture content ranging from about 4% to about 12% by weight.
[0085] In some embodiments, a dry food composition described herein can have a Metabolizable Energy (ME) ranging from about 2500 kcal / kg to about 5000 kcal / kg, or from about 2800 kcal / kg to 5000 kcal / kg, or from about 3000 kcal / kg to about 4000 kcal / kg, or from about 3500 kcal / kg to about 4500 kcal / kg or from about 3600 kcal / kg to about 4300 kcal / kg, as measured according to the NRC 2006.
[0086] In some embodiments, a dry food composition as disclosed herein can have a Metabolizable Energy (ME) of about 3600 kcal / kg, or about 3700 kcal / kg, or about 3800 kcal / kg, or about 3900 kcal / kg, or about 4000 kcal / kg, or about 4100 kcal / kg, or about 4200 kcal / kg, or about 4300 kcal / kg, as measured according to the NRC 2006.
[0087] In some embodiments, a food composition described herein can be a wet food composition, typically having a moisture content ranging from about 50% to about 90% by weight.
[0088] In some embodiments, a wet food composition described herein can have a Metabolizable Energy ranging from about 400 kcal / kg to about 1600 kcal / kg, or from about 500 kcal / kg to about 1500 kcal / kg, or from about 600 kcal / kg to about 1400 kcal / kg, or from about 700 kcal / kg to about 1200 kcal / kg, as measured according to the NRC 2006.
[0089] In some embodiments, a wet food composition described herein can have a Metabolizable Energy of about 600 kcal / kg, or about 700 kcal / kg, or about 900 kcal / kg, or about 950 kcal / kg, or about 1000 kcal / kg, or about 1050 kcal / kg, or aboutAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 1100 kcal / kg, or about 1150 kcal / kg, or about 1200 kcal / kg, as measured according to the NRC 2006.
[0090] When the amount of nutritional ingredients in a food composition is expressed as a percentage (%), a skilled person can convert it into grams per megacalorie using the following formula: Multiply the percentage of the ingredient as fed by 10, then by 1000, and finally divide by the metabolizable energy (ME) of the food as determined by the NRC 2006. In other words, the formula for converting to grams per megacalorie is: X g / Mcal = (% as fed *10*1000) / ME NRC 2006.The food composition
[0091] The present disclosure relates to a food composition including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) with a specific mass ratio and total amount of EPA to DHA.
[0092] A food composition described herein is intended to be used for treating and / or preventing feline atopic dermatitis in a feline in need thereof.
[0093] A food composition described herein includes EPA and DHA.
[0094] In some embodiments, a food composition described herein includes EPA and DHA as the sole active agents. In particular, EPA and DHA are the sole actives agents for the present intended used, specifically for treating and / or preventing feline atopic dermatitis.
[0095] In some embodiments, a food composition described herein can be a nutritionally complete and balanced food composition.
[0096] In some embodiments, a food composition described herein can be a functional complement.
[0097] In some embodiments, a food composition described herein can present a mass ratio of EPA to DHA from about 0.2: 1 to about 1:1.
[0098] In some embodiments, a food composition described herein can present a mass ratio of EPA to DHA from about 0.2:1 to about 0.95:1, or from about 0.2:1 to about 0.9:1, or from about 0.2: 1 to about 0.85: 1 , or from about 0.2: 1 to about 0.8:1, or from about 0.2:1 to about 0.75:1, or from about 0.2:1 to about 0.7:1; or from about 0.25:1 to about 0.95:1, or from about 0.25:1 to about 0.9:1, or from about 0.25:1 to about 0.85: 1 , or from about 0.25: 1 to about 0.8:1, or from about 0.25: 1 to about 0.75: 1 , or from about 0.25:1 to about 0.7:1; or from about 0.3:1 to about 0.9:1, or from about 0.3:1 to about 0.8:1; or from about 0.35:1 to about 0.95:1, or from about 0.35:1 to about 0.90:1, or from about 0.35:1 to about 0.85:1, or from about 0.35:1 to aboutAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 0.80:1, or from about 0.35:1 to about 0.75:1, or from about 0.35:1 to about 0.7:1; or from about 0.4:1 to about 0.9:1, or from about 0.4:1 to about 0.85:1, or from about 0.4: 1 to about 0.8:1, or from about 0.4: 1 to about 0.75: 1 , or from about 0.4: 1 to about 0.7:1.
[0099] In some embodiments, a food composition described herein can present a mass ratio of EPA to DHA of about 0.2:1, or about 0.25:1, or about 0.3:1, or about 0.35:1, or about 0.4:1, or about 0.45:1, or about 0.47:1, or about 0.5:1, or about 0.55:1, or about 0.6:1 , or about 0.65:1 , or about 0.7:1 , or about 0.75:1 or about 0.8:1 , or about 0.85:1, or about 0.9:1.
[0100] The food composition, for instance a nutritionally complete and balanced feline food composition, described herein includes EPA and DHA wherein the mass ratio of EPA to DHA can be from about 0.2: 1 to about 1 : 1 and wherein the total amount of EPA and DHA can be from about 0.1 g / Mcal to about 20 g / Mcal.
[0101] In some embodiments, the total amount of EPA and DHA of the food composition described herein can be from about 0.1 g / Mcal to about 20 g / Mcal, or from about 0.1 g / Mcal to about 18 g / Mcal, or from about 0.1 g / Mcal to about 15 g / Mcal, or from about 0.1 g / Mcal to about 13 g / Mcal, or from about 0.1 g / Mcal to about 11 g / Mcal, or from 0.5 g / Mcal to about 15 g / Mcal, or from 0.5 g / Mcal to about 12 g / Mcal, or from about 0.5 g / Mcal to about 10 g / Mcal, or from about 0.5 g / Mcal to about 8 g / Mcal, or from about 0.2 g / Mcal to about 9 g / Mcal, or from about 0.2 g / Mcal to about 7 g / Mcal, or from about 0.25 g / Mcal to about 5 g / Mcal, or from about 0.25 g / Mcal to about 3 g / Mcal, or from about 0.25 g / Mcal to about 2 g / Mcal.
[0102] In some embodiments, the total amount of EPA and DHA of the food composition described herein can be of about 0.1 g / Mcal, or about 0.15 g / Mcal, or about 0.2 g / Mcal, or about 0.25 g / Mcal, or about 0.3 g / Mcal, or about 0.35 g / Mcal, or about 0.4 g / Mcal, or about 0.45 g / Mcal, or about 0.5 g / Mcal, or about 0.55 g / Mcal, or about 0.6 g / Mcal, or about 0.65 g / Mcal, or about 0.7 g / Mcal, or about 0.75 g / Mcal, or about 0.8 g / Mcal, or about 0.85 g / Mcal, or about 0.9 g / Mcal, or about 0.95 g / Mcal, or about 1 g / Mcal, or about 1.1 g / Mcal, or about 1.15 g / Mcal, or about 1.2 g / Mcal, or about 1.25 g / Mcal, or about 1.3 g / Mcal, or about 1.35 g / Mcal, or about 1.4 g / Mcal, or about 1.45 g / Mcal, or about 1.5 g / Mcal, or about 1.55 g / Mcal, or about 1.65 g / Mcal, or about 1.7 g / Mcal, or about 1.75 g / Mcal, or about 1.8 g / Mcal, or about 1.82 g / Mcal, or about 1.85 g / Mcal, or about 1.9 g / Mcal, or about 1.95 g / Mcal, or about 2 g / Mcal.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0103] In some embodiments, the food composition described herein can include from about 0.05 g / Mcal to about 10 g / Mcal of EPA. In some embodiments, the food composition described herein can include from about 0.05 g / Mcal to about 5 g / Mcal of EPA.
[0104] In some embodiments, the food composition described herein can include from about 0.05 g / Mcal to about 9 g / Mcal, or from about 0.05 g / Mcal to about 8.5 g / Mcal, or from about 0.05 g / Mcal to about 8 g / Mcal, or from about 0.05 g / Mcal to about 7.5 g / Mcal, or from about 0.05 g / Mcal to about 7 g / Mcal, or from about 0.05 g / Mcal to about 6.5 g / Mcal, or from about 0.05 g / Mcal to about 6 g / Mcal, or from about 0.05 g / Mcal to about 5.5 g / Mcal, or from about 0.05 g / Mcal to about 5 g / Mcal, or from about 0.05 g / Mcal to about 3 g / Mcal, or from about 0.05 g / Mcal to about 2 g / Mcal, or from about 0.05 g / Mcal to about 1 g / Mcal of EPA.
[0105] In some embodiments, the food composition described herein can include about 0.05 g / Mcal, or about 0.1 g / Mcal, or about 0.15 g / Mcal, or about 0.2 g / Mcal, or about 0.25 g / Mcal, or about 0.3 g / Mcal, or about 0.35 g / Mcal, or about 0.4 g / Mcal, or about 0.45 g / Mcal, or about 0.5 g / Mcal, or about 0.52 g / Mcal, or about 0.55 g / Mcal, or about 0.6 g / Mcal, or about 0.65 g / Mcal, or about 0.7 g / Mcal, or about 0.75 g / Mcal, or about 0.8 g / Mcal, about 0.9 g / Mcal, or about 1 g / Mcal of EPA.
[0106] In some embodiments, the food composition described herein can include from about 0.05 g / Mcal to about 20 g / Mcal of DHA. In some embodiments, the food composition described herein can include from about 0.2 g / Mcal to about 10 g / Mcal of DHA.
[0107] In some embodiments, the food composition described herein can include from about 0.05 g / Mcal to about 15 g / Mcal, or from about 0.1 g / Mcal to about 10 g / Mcal; or from 0.15 g / Mcal to about 15 g / Mcal, or from about 0.2 g / Mcal to about 10 g / Mcal, or from about 0.05 g / Mcal to about 7 g / Mcal, or from about 0.05 g / Mcal to about 6.5 g / Mcal, or from about 0.05 g / Mcal to about 6 g / Mcal, or from about 0.05 g / Mcal to about 5.5 g / Mcal, or from about 0.05 g / Mcal to about 5 g / Mcal, or from about 0.05 g / Mcal to about 3 g / Mcal, or from about 0.05 g / Mcal to about 2 g / Mcal of DHA.
[0108] In some embodiments, the food composition described herein can include about 0.2 g / Mcal, or about 0.3 g / Mcal, or about 0.4 g / Mcal, or about 0.5 g / Mcal, or about 0.6 g / Mcal, or about 0.7 g / Mcal, or about 0.8 g / Mcal, or about 0.9 g / Mcal, or about 1 g / Mcal, or about 1.1 g / Mcal, or about 1.2 g / Mcal, or about 1.3 g / Mcal, or aboutAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 1.4 g / Mcal, or about 1.5 g / Mcal, or about 1.6 g / Mcal, or about 1.7 g / Mcal, or about 1.8 g / Mcal, or about 1.9 g / Mcal, or about 2 g / Mcal of DHA.
[0109] In some embodiments, a source of EPA and DHA can be selected from, without limitation, fish oil, fish meal, algae oil, eggs, oyster, chia seed, walnuts, soybeans, Green Leaped Mussel or a mixture thereof.
[0110] In some embodiments, a source of EPA and DHA can substantially consist of algae oil.
[0111] The source of EPA and DHA can significantly influence the EPA: DHA ratio in the food composition. Fish oil, which is the most common source of EPA and DHA in prior art compositions, typically provides an EPA:DHA ratio greater than 1:1, often ranging from about 1.5:1 to about 3:1. This is because fish oil naturally contains higher amounts of EPA relative to DHA. In contrast, algae oil typically provides an EPA: DHA ratio where DHA content is higher than EPA content, with EPA: DHA ratios typically ranging from about 0.3:1 to about 0.6:1. Algae oil is therefore a preferred source of EPA and DHA for achieving the claimed EPA: DHA ratio of from about 0.2:1 to about 1:1 in the food composition described herein.
[0112] Without being bound by theory, it is believed that the specific EPA: DHA ratio with more DHA than EPA, as achieved through the use of algae oil as the primary source, may be particularly effective for treating feline atopic dermatitis. DHA has been shown to have potent anti-inflammatory properties and may play a role in modulating the immune response associated with feline atopic dermatitis. The examples described herein demonstrate the efficacy of a food composition comprising EPA and DHA primarily from algae oil in reducing clinical scores associated with feline atopic dermatitis.
[0113] In some embodiments, the source of EPA and DHA can comprise a combination of algae oil and fish oil, wherein algae oil provides the majority of the EPA and DHA content. For instance, algae oil can provide at least about 80%, or at least about 85%, or at least about 90%, or at least about 95% of the total EPA and DHA content in the food composition as described herein.
[0114] The food composition described herein can include curcuminoids.
[0115] In some embodiments, the food composition described herein can include from about 0.1 g / Mcal to about 2 g / Mcal of curcuminoids.
[0116] In some embodiments, the food composition described herein can include from about 0.11 g / Mcal to about 1.8 g / Mcal, or from about 0.12 g / Mcal to aboutAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 1.6 g / Mcal, or from about 0.14 g / Mcal to about 1.4 g / Mcal, or from about 0.16 g / Mcal to about 1.2 g / Mcal, or from about 0.18 g / Mcal to about 1 g / Mcal, or from about 0.2 g / Mcal to about 0.8 g / Mcal, or from about 0.2 g / Mcal to about 0.6 g / Mcal of curcuminoids.
[0117] In some embodiments, the food composition described herein can include about 0.2 g / Mcal, or about 0.22 g / Mcal, or about 0.25 g / Mcal, or about 0.27 g / Mcal, or about 0.3 g / Mcal, or about 0.32 g / Mcal, or about 0.35 g / Mcal, or about 0.37 g / Mcal or about 0.4 g / Mcal, or about 0.42 g / Mcal , or about 0.45 g / Mcal, or about 0.5 g / Mcal, or about 0.52 g / Mcal, or about 0.55 g / Mcal, or about 0.57 g / Mcal, or about 0.6 g / Mcal of curcuminoids.
[0118] In some embodiments, curcuminoids can include curcumin or a derivative of curcumin.
[0119] In some embodiments, curcuminoids can include curcumin, demethoxycurcumin, bisdemethoxycurcumin and / or tetrahydrocurcumin.
[0120] In some embodiments, the curcuminoid included within the food composition described herein can be of any format, including a powder or lipid extract.
[0121] In some embodiments, a source of curcuminoid can be, without limitation, a root of turmeric.
[0122] In some embodiments, curcuminoid can be mixed with phospholipids and / or cellulose, starch or derivatives thereof to form complexes. This may assist in stability and / or to further increase solubility and bioavailability of the curcuminoid.
[0123] As non-limitative example, the curcuminoid can be mixed with, without limitation, essential oils, piperine or bromelain. The curcuminoid can also be mixed with phosphatidycholine, for example lecithin.
[0124] In some embodiments, curcuminoids can be curcumin, which is the most active curcuminoid. In some embodiments, curcumin according to the present disclosure can encompass demethoxycurcumin, bisdemethoxycurcumin and / or tetrahydrocurcumin.
[0125] In some embodiments, EPA, DHA and curcuminoids are the sole active agents. In particular, EPA, DHA and curcuminoids are the sole actives agents for the present intended used, specifically for treating and / or preventing feline atopic dermatitis
[0126] In some embodiments, the food composition described herein can include other nutrients and / or ingredients.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0127] In some embodiments, the food composition described herein can further include, but is not limited to, proteins, carbohydrates, fibers, fats, vitamins and / or minerals.
[0128] In some embodiments, the food composition can further include Linoleic acid.
[0129] In some embodiments, the food composition can further include Taurine.
[0130] In some embodiments, the food composition can further include Lutein.
[0131] In some embodiments, the food composition can further include Vitamin E.
[0132] In some embodiments, the food composition described herein can further include Linoleic acid, Taurine, Lutein, Vitamin E, or combinations thereof.
[0133] In some embodiments, a food composition described herein can include from about 4.5 g / Mcal to about 23 g / Mcal of Linoleic acid. In some embodiments, a food composition described herein can include about 4.5 g / Mcal, about 5 g / Mcal, about 6g / Mcal, about 7 g / Mcal, about 8 g / Mcal, about 9 g / Mcal, about 10 g / Mcal, about 11 g / Mcal, about 12 g / Mcal, about 13 g / Mcal, about 14 g / Mcal, about 15 g / Mcal, about 16g / Mcal, about 17g / Mcal, about 18g / Mcal, about 19 g / Mcal, about 20 g / Mcal, about 21 g / Mcal, about 22 g / Mcal or about 23 g / Mcal of Linoleic acid.
[0134] In some embodiments, a dry food composition described herein can include from about 2% to about 10% by weight of Linoleic acid, on a dry matter basis. In some embodiments, a food composition described herein can include about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9% or about 10% by weight of Linoleic acid, on a dry matter basis.
[0135] In some embodiments, a food composition described herein can include from about 0.2 g / Mcal to about 5 g / Mcal of Taurine. In some embodiments, a food composition described herein can include about 0.2 g / Mcal, about 0.3 g / Mcal, about 0.4 g / Mcal, about 0.5 g / Mcal, about 0.6 g / Mcal, about 0.7 g / Mcal, about 0.9 g / Mcal, about 1 g / Mcal, about 1.1 g / Mcal, about 1.2 g / Mcal, about 1.3 g / Mcal, about 1.4 g / Mcal, about 1.5 g / Mcal, about 1.6 g / Mcal, about 1.7 g / Mcal, about 1.8 g / Mcal about 1.9 g / Mcal, about 2 g / Mcal, about 2.5 g / Mcal, about 3 g / Mcal, about 3.5 g / Mcal, about 4 g / Mcal, about 4.5 g / Mcal or about 5 g / Mcal of Taurine.
[0136] In some embodiments, a dry food composition described herein can include from about 0.1% to about 2% by weight of Taurine, on a dry matter basis. In some embodiments, a food composition described herein can include about 0.1%,Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1 %, about 1.1%, about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9% or about 2% by weight of Taurine, on a dry matter basis.
[0137] In some embodiments, a food composition described herein can include from about 0.002 g / Mcal to about 0.015 g / Mcal of Lutein. In some embodiments, a food composition described herein can include about 0.002 g / Mcal, about 0.003 g / Mcal, about 0.004 g / Mcal, about 0.005 g / Mcal, about 0.006 g / Mcal, about 0.007 g / Mcal, about 0.008 g / Mcal, about 0.009 g / Mcal, about 0.01, about 0.011 g / Mcal, about 0.012 g / Mcal, about 0.013 g / Mcal, about 0.014 g / Mcal or about 0.015 g / Mcal of Lutein.
[0138] In some embodiments, a dry food composition described herein can include from about 4 ppm to about 20 ppm of Lutein, on a dry matter basis. In some embodiments, a food composition described herein can include about 4 ppm, about 5 ppm, about 6 ppm, about 7 ppm, about 8 ppm, about 9 ppm, about 10 ppm, about 11 ppm, about 12 ppm, about 13 ppm, about 14 ppm, about 15 ppm, about 16 ppm, about 17 ppm, about 18 ppm, about 19 ppm or about 20 ppm of Lutein, on a dry matter basis.
[0139] In some embodiments, a food composition described herein can include from about 0.1 g / Mcal to about 1.5 g / Mcal of Vitamin E. In some embodiments, a food composition described herein can include about 0.1 g / Mcal, about 0.2 g / Mcal, about 0.3 g / Mcal, about 0.4 g / Mcal, about 0.5 g / Mcal, about 0.6 g / Mcal, about 0.7 g / Mcal, about 0.8 g / Mcal, about 0.9 g / Mcal, about 1 g / Mcal, about 1.1 g / Mcal, about 1.2 g / Mcal, about 1.3 g / Mcal, about 1.4 g / Mcal or about 1.5 g / Mcal of Vitamin E.
[0140] In some embodiments, a dry food composition described herein can include from about 300 ppm to about 4500 ppm of Vitamin E, on a dry matter basis. In some embodiments, a food composition described herein can include about 300 ppm, about 350 ppm, about 400 ppm, about 450 ppm, about 500 ppm, about 550 ppm, about 600 ppm, about 650 ppm, about 700 ppm, about 750 ppm, about 800 ppm, about 850 ppm, about 900 ppm, about 950 ppm, about 1000 ppm, about 1100 ppm, 1200 ppm, 1300 ppm, 1400 ppm, 1500 ppm, 1600 ppm, 1700 ppm, 1800 ppm, 1900 ppm, 2000 ppm, 2500 ppm, 3000ppm, 3500 ppm, 4000 ppm or about 4500 ppm of Vitamin E, on a dry matter basis.
[0141] In a particular embodiment, a food composition described herein includes docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA);Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 wherein the mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3:1 to about 0.9:1, and the total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal,and wherein the said composition can further include at least one of:- from about 4.5 g / Mcal to about 23 g / Mcal of linoleic acid;- from about 0.2 g / Mcal to about 5 g / Mcal of Taurine;- from about 0.002 g / Mcal to about 0.015 g / Mcal of Lutein;- from about 0.1 g / Mcal to about 1.5 g / Mcal of Vitamin E;or a combination thereof.
[0142] In a particular embodiment, a food composition described herein includes docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA);wherein the mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3:1 to about 0.9:1, and the total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal,and wherein the said composition can further include at least one of:- from about 0.1 g / Mcal to about 2 g / Mcal of curcuminoids;- from about 4.5 g / Mcal to about 23 g / Mcal of linoleic acid;- from about 0.2 g / Mcal to about 5 g / Mcal of Taurine;- from about 0.002 g / Mcal to about 0.015 g / Mcal of Lutein;- from about 0.1 g / Mcal to about 1.5 g / Mcal of Vitamin E;or a combination thereof.
[0143] Notably, in such embodiments, these proteins, carbohydrates, fibers, fats, vitamins and / or minerals are supplementary or in complement to the EPA and DHA content, and optionally the curcuminoids, incorporated into the food composition described herein.
[0144] Accordingly, the amount of the other nutrients and / or ingredients shall be present in an adequate amount to ensure maintenance of lean body mass of the feline while no being toxic for the feline.
[0145] In some embodiments, the food composition described herein can include proteins.
[0146] Accordingly, the protein level shall be high enough to ensure maintenance of lean body mass of the feline, particularly the canine or the feline while no being toxic for the feline, particularly the canine or the feline.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0147] In some embodiments, a food composition described herein can include from about 40 g / Mcal to about 120 g / Mcal of protein. In some particular embodiments, a food composition described herein can include from about 80 g / Mcal to 120 g / Mcal of protein.
[0148] In some embodiments, a food composition described herein can include about 40 g / Mcal g / Mcal, about 50 g / Mcal, about 55 g / Mcal, about 60 g / Mcal, about 65 g / Mcal about 70 g / Mcal, about 75 g / Mcal, about 80 g / Mcal, about 85 g / Mcal, about 90 g / Mcal, about 95 g / Mcal, about 100 g / Mcal about 110 g / Mcal or about 120 g / Mcal of protein.
[0149] In some embodiments, a dry food composition described herein can include from about 15% to about 45% by weight of protein, on a dry matter basis.
[0150] In some embodiments, a dry food composition described herein can include about 15%, about 16%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24%, about 25%, about 26%, about 27%, about 28%, about 29%, about 30%, about 31%, about 32%, about 33%, about 34%, about 35%, about 36%, about 37%, about 38%, about 39%, about 40%, about 41%, about 42%, about 43%, about 44%, about 45% by weight protein, on a dry matter basis.
[0151] In some embodiments, a food composition described herein can include a plurality of source of proteins. In some embodiments, the protein can be nonhydrolyzed protein. In some embodiments, the protein can be hydrolyzed protein. An ingredient that can be a protein source for the manufacture of a food composition described herein can originate from an animal protein source and / or a vegetal protein source. Notably, an animal protein source and / or a vegetal protein source can be a raw material.
[0152] In some embodiments, a protein source can be a mixture of one or more animal protein source or one or more vegetable protein source, or one or more animal and vegetal protein sources. A source of protein in a raw material can also provide to the food composition described herein a source of water, a source of fat, a source of ash, a source of fibers, and / or a source of vitamins. The nutritional composition of the source of protein depending on the quality and the specificity of the raw material. For instance, an animal source of protein can also provide fats.
[0153] An animal protein source can be selected from, but is not limited to, poultry, poultry meal, poultry by-product, lamb, lamb meals, pork, pork by-product, beef, beef by-products, white fish, milk proteins, egg, venison or a combination thereof.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0154] Poultry can encompass chicken, duck, turkey, geese, and quail.
[0155] A vegetable protein source can be selected, without limitation, from soybean meal, soy protein isolate, rice, soy protein concentrate, maize gluten, wheat gluten, gluten, tofu, green lentils, carrot, potato, beets, corn gluten meal, corn protein concentrate or a combination thereof.
[0156] Protein content of a food composition can be determined by any methods known by the person of skill in the art.
[0157] In some embodiments, the food composition described herein can include fats.
[0158] In some embodiments, the food composition can include fats from an animal fat source and / or a vegetable fat source. A vegetable fat source can include, without limitation, wheat, soy, sunflower, safflower, rapeseed, olive, borage, flaxseed, peanuts, blackcurrant seed, cottonseed, wheat, germ, com germ as well as oils derived from these and combinations thereof. An animal fat source can include, without limitation, chicken crude fat, turkey crude fat, beef crude fat, duck crude fat, pork crude fat, lamb crude fat, fish oil or any meat, meat by-products, seafood, fish byproducts, dairy, eggs or a combination thereof.
[0159] Fats can be supplied by any sources known by the person skilled in the art.
[0160] In some embodiments, a food composition described herein can include from about 25 g / Mcal to about 80 g / Mcal of fat. In some particular embodiments, a food composition described herein can include from about 40 g / Mcal to about 80 g / Mcal of fat.
[0161] In some embodiments, a food composition described herein can include about 25 g / Mcal g / Mcal, about 30 g / Mcal, about 35 g / Mcal, about 40 g / Mcal, about 45 g / Mcal about 50 g / Mcal, about 55 g / Mcal, about 60 g / Mcal, about 65 g / Mcal, about 70 g / Mcal, about 75 g / Mcal or about 80 g / Mcal of fat.
[0162] In some embodiments, a dry food composition described herein can include from about 10% to about 30% by weight of fat, on a dry matter basis.
[0163] In some embodiments, a dry food composition described herein can include about 10%, about 11%, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, about 20%, about 21%, about 22%, about 23%, about 24%, about 25%, about 26%, about 27%, about 28%, about 29% or about 30% by weight of fat, on a dry matter basis.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0164] The total amount of fat in the food compositions described herein includes the amount of EPA and DHA.
[0165] Fat content of a food composition described herein can be determined by any methods known by the person of skill in the art.
[0166] In some embodiments, the food composition described herein can include fibers. As used herein the term “fibers” designates soluble fibers and insoluble fibers.
[0167] In some embodiments, the food composition described herein can include from about 5 g / Mcal to about 35 g / Mcal of fiber.
[0168] In some embodiments, a food composition described herein can include about 5 g / Mcal g / Mcal, about 10 g / Mcal, about 15 g / Mcal, about 20 g / Mcal, about 25 g / Mcal, about 30 g / Mcal or about 35 g / Mcal of fiber.
[0169] In some embodiments, a dry food composition described herein can include from about 2% to about 15% by weight of fiber, on a dry matter basis.
[0170] In some embodiments, a dry food composition described herein can include about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 11%, about 12%, about 13%, about 14%, about 15% by weight of fiber, on a dry matter basis.
[0171] In some embodiments, a source of fibers can be selected from, but is not limited to, beet pulp, guar gum, chicory root, psyllium, pectin, blueberry, cranberry, squash, apples, oats, beans, citrus, barley, or peas cellulose, whole wheat products, wheat oat, com bran, flax seed, grapes, celery, green beans, cauliflower, potato skins, fruit skins, vegetable skins, peanut hulls, soy fiber and a combination thereof.
[0172] Fiber’s content of a food composition described herein can be determined by any methods known by the person of skill in the art.
[0173] In some embodiments, the food composition as described herein can also include ash.
[0174] In some embodiments, the food composition described herein can include from about 10 g / Mcal to about 25 g / Mcal of ash.
[0175] In some embodiments, some embodiments, a food composition described herein can include about 10 g / Mcal g / Mcal, about 11 g / Mcal, about 12 g / Mcal, about 13 g / Mcal, about 14 g / Mcal, about 15 g / Mcal, about 16 g / Mcal, about 17 g / Mcal, about 18 g / Mcal, about 19 g / Mcal, about 20 g / Mcal, about 21 g / Mcal, about 22 g / Mcal, about 23 g / Mcal, about 24 g / Mcal, or about 25 g / Mcal of ash.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0176] In some embodiments, a dry food composition described herein can include from about 3.5% to about 8% by weight of ash, on a dry matter basis.
[0177] In some embodiments, a dry food composition described herein can include about 3.5%, about 4%, about 4.5%, about 5%, about, 5.5%, about 6%, about 6.5%, about 7%, about 7.5% or about 8% by weight of ash, on a dry matter basis.
[0178] In some embodiments, the food composition as described can also include preservatives, trace elements and / or coloring.
[0179] In some embodiments, a food composition described herein can further include a diluent and / or an excipient.
[0180] A diluent can encompass water or broth or stock. Broth can generally be made by simmering meat, such as chicken, beef or fish, or vegetables in water. Stock can generally be made by simmering bones in water, and eventually with vegetables and / or meat.
[0181] An excipient can encompass antioxidants, flavors, prebiotics, probiotics or Taurine.
[0182] In some embodiments, a food composition described herein does not include glycyrrhizin.
[0183] Typically, a food composition disclosed herein can include EPA and DHA and, optionally, one or more further ingredient such as a source of protein, a source of ash, a source of fibers, a source of fat, additives and / or vitamins. The sum of the weight of each of the ingredients comprised therein amounting, on a dry matter basis, to 100% by weight.
[0184] Typically, a food composition as disclosed herein can include several substances and / or nutriments such as protein, ash, fibers, fat, additives and / or vitamins. The sum of the weight of each of the substances and / or nutriments comprised therein amounting, on a dry matter basis, to 100% by weight.
[0185] In some embodiments, a food composition described herein can consist of a wet food composition, a dry food composition or a semi-moist food composition.
[0186] In some embodiments, a food composition described herein can consist of functional complement.
[0187] A dry food composition can refer to a food composition having a moisture content of less than about 12% by weight, relative to the total weight of the food composition.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0188] A process for determining the moisture content of a food composition can include at least the steps of (i) selecting a representative sample of the food composition, (ii) weighing the sample, (iii) then subjecting the sample to complete dehydration in a temperature-controlled oven, typically around 100°C, until all water is evaporated, (iv) after cooling in a desiccator, weighing again the dehydrated sample. The moisture content is then calculated using the formula: Moisture Content (%) = [(Initial Mass - Mass after dehydration) I Initial Mass] x 100.
[0189] In some embodiments, a dry food composition described herein can have a moisture content ranging from about 4% to about 12% by weight, relative to the total weight of the food composition.
[0190] In some embodiments, a dry food composition described herein can have a moisture content of about 4%, or about 5%, or about 6%, or about 7%, or about 8%, or about 9%, or about 10%, or about 11 %, or about 12% by weight, relative to the total weight of the food composition.
[0191] Typically, a dry food composition can have a moisture content of about 8% by weight, relative to the total weight of the food composition.
[0192] In some embodiments, a dry food composition can be formed by an extrusion process.
[0193] In some embodiments, a dry food composition can be formed from a core and a coating to form a dry food composition that is coated, also called a coated dry animal food composition.
[0194] In some embodiments, a dry food composition can be a kibble.
[0195] A semi-moist food composition refers to a food composition having a moisture content ranging from about 13% to about 49 % by weight, relative to the total weight of the food composition.
[0196] Typically, a semi-moist food composition is the final product of a process allowing a moisture content value that is intermediate between a dry food and a wet food. In some embodiments, the said process can comprise a step of adding a humectant agent. In some embodiments, the said process can comprise an extrusion step and a subsequent treatment step with Super-Heated Stream (SHS). As non-limitative example, semi-moist food can be obtained using Super-Heated Stream (SHS) processes such as processes or methods described in the published patent applications W02009 / 018990, W02009 / 018996, WO2010 / 112097, WO2014 / 122072,Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 WO2016 / 071372 and / or WO2016 / 071367, the disclosures of which are incorporated herein in their entireties.
[0197] In some embodiments, a semi-moist food composition described herein can have a moisture content of about 13%, or about 14%, or about 15%, or about 16%, or about 17% or about 18, or about 9%, or about 20% or about 21%, or about 22%, or about 23%, or about 24%, or about 25%, or about 26%, or about 27%, or about 28%, or about 29%, or about 30%, or about 31 %, or about 32%, or about 33%, or about 34%, or about 35%, or about 36%, or about 37%, or about 38%, or about 39%, or about 40%, or about 41 %, or about 42%, or about 43%, or about 44%, or about 45%, or about 46%, or about 47%, or about 48%, or about 49% by weight, relative to the total weight of the food composition.
[0198] Typically, a semi-moist food composition can have a moisture content of about 20% by weight, relative to the total weight of the food composition.
[0199] A wet food composition refers to a food composition having a moisture content of more than about 50% by weight, relative to the total weight of the food composition.
[0200] In some embodiments, a wet food composition refers to a food composition having a moisture content ranging from about 50% to about 90% by weight, relative to the total weight of the food composition.
[0201] In some embodiments, a wet food composition described herein can have a moisture content of about 50%, or about 55%, or about 60%, or about 65%, or about 70%, or about 75%, or about 80%, or about 85%, or about 90% by weight, relative to the total weight of the food composition.
[0202] Typically, a wet food composition can have a moisture content of about 80% by weight, relative to the total weight of the food composition.
[0203] In general, a wet food composition is the final product of a process including a final step of sterilization (instead of a drying step).
[0204] In some embodiments, a wet food composition can consist of a chunk form, more particularly of chunks in gravy form.
[0205] In some embodiments, a wet food composition can consist of chunks and gravy, chunks in jelly, loaf, mousse, terrine or bites form.
[0206] In some particular embodiments, a food composition described herein can consist of a dry food composition.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0207] In some embodiments, a functional complement can consist of chews, soft chews, tablets, powders, liquids, beads, gums, or any other similar format known by the person skilled in the art.
[0208] The food composition as disclosed herein is nutritionally complete and balanced; and palatable for a feline.
[0209] The food composition as disclosed herein is a functional complement, and palatable for a feline.
[0210] In some embodiments, a feline can encompass a cheetah, a puma, a jaguar, a leopard, a lion, a lynx, a liger, a tiger, a panther, a bobcat, an ocelot, a smilodon, a caracal, a serval and / or a cat.
[0211] In some embodiments, a feline can be a cat, in particular a domestic cat.Uses and methods
[0212] An object of the present disclosure relates to a food composition described herein for use (in a method) for managing, treating and / or preventing feline atopic dermatitis in a feline in need thereof.
[0213] An object of the present disclosure relates to a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof comprising at least a step of providing a food composition described herein to the feline.
[0214] An object of the present disclosure relates to the use of a food composition described herein in the manufacture of a medicament for managing, treating and / or preventing feline atopic dermatitis in a feline in need thereof.
[0215] An object of the present disclosure relates to the use of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in the manufacture of a food composition or medicament for managing, treating and / or preventing feline atopic dermatitis in a feline in need thereof, wherein the mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3: 1 to about 0.9:1, and the total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal, as described herein.
[0216] In particular, the method comprises administering to said feline, a food composition which comprises EPA and DHA, and optionally curcuminoids, as described herein.
[0217] In some embodiments, feline atopic dermatitis is an environmental allergen-induced atopic dermatitis, in particular an environmental allergen-induced feline atopic dermatitis. An environmental allergen can be one or more pollen(s), one or more insect(s), one or more mite(s), one or more mold(s), or combinations thereof.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0218] A pollen environmental allergen can be, without limitation, grass, weed, and / or tree.
[0219] An insect environmental allergen can be, without limitation, mosquito, ant, moth, and / or horsefly.
[0220] A mite environmental allergen can be, without limitation, a house dust mite (e.g. dermatophagoides farinae and dermatophagoides pteronyssinus), a storage mite (e.g. Acarus siro, Glyciphagus domesticus, and Tyrophagus putrescentiae), and / or a grain mill dust.
[0221] In some embodiments, feline atopic dermatitis is a nonflea dermatitis and / or a nonflea allergy dermatitis. In some embodiments, feline atopic dermatitis is a nonflea, environmental allergen-induced feline hypersensitivity dermatitis.
[0222] In some embodiments, feline atopic dermatitis is a non-food allergy atopic dermatitis. Otherwise said, in some embodiments, feline atopic dermatitis is a non-food induced feline hypersensitivity dermatitis. In some embodiments, feline atopic dermatitis is a nonfood, environmental allergen-induced feline hypersensitivity dermatitis.
[0223] In some embodiments, feline atopic dermatitis is a nonflea, nonfood-induced feline hypersensitivity dermatitis. In some embodiments, feline atopic dermatitis is a nonflea, nonfood, environmental allergen-induced feline hypersensitivity dermatitis.
[0224] In some embodiments, feline atopic dermatitis is a non-parasite induced atopic dermatitis, the parasite being selected from, without limitation, Demodex mites, Notoedres, Cheyletiella, Otodectes, trombiculid mites, and Lynxacarus.
[0225] In some embodiments, feline atopic dermatitis is a non-infection induced atopic dermatitis.
[0226] In some embodiments, feline atopic dermatitis is a feline atopic skin syndrome (FASS).
[0227] In some embodiments, the treatment of feline atopic dermatitis with the food composition described can include the reduction of the severity of feline atopic dermatitis and symptoms thereof.
[0228] In some embodiments, the treatment of feline atopic dermatitis with the food composition described can include the reduction of the severity of skin inflammation, the reduction of the severity of itching, and / or the reduction of selfinduced alopecia by the feline.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0229] In some embodiments, the treatment of feline atopic dermatitis with the food composition described can include the reduction of the seventy of pruritus on the feline’s body, in particular the face, the head and / or the neck of the feline.
[0230] In some embodiments, the treatment of feline atopic dermatitis with the food composition described can include the reduction of the frequency and / or the dosage of one or more of anti-feline atopic dermatitis agent(s).
[0231] In some embodiments, the treatment of feline atopic dermatitis with the food composition described can include the reduction of skin excoriations or erosions.
[0232] In some embodiments, the treatment of feline atopic dermatitis with the food composition described herein can include the amelioration of the life condition of the feline that is fed.
[0233] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be administered to the feline daily as part of its diet.
[0234] In the field of pet nutrition, it is well-established that those skilled in the art possess the knowledge and expertise to adapt the formulation of a food composition to align with specific feeding recommendations for the target animal. For instance, if the recommendation specifies that a feline should be fed once a day, twice a day, and / or only on specific days of the week, the skilled person can readily modify the food composition accordingly.
[0235] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be provided to the feline in alternation with another food composition. In some embodiments, the said another food composition can be another nutritionally complete and balanced food composition or a functional complement. In particular, another food composition can be selected from food compositions in the art, including the large variety of commercialized food compositions adapted to canines orfelines.
[0236] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be provided to the feline in need thereof every other day, with said another food composition being provided on alternate days.
[0237] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof,Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 can be formulated to be provided to the feline in need thereof from several weeks to several years, depending notably on the severity of the symptoms.
[0238] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be suitable to be provided to the feline in need thereof once a day or twice a day.
[0239] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be suitable to be provided to the feline in need thereof every day in a week over a period of 1 month or more, or 2 months or more, or 3 months or more, or 4 months or more, or 5 months or more.
[0240] In some embodiments, a food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated to be provided to a feline in need thereof during a longer period of time, such as during 6 months or more, or 12 months or more, either (i) according to a feeding schedule wherein the feline exclusively fed the food composition described herein or (ii) according to a feeding schedule wherein the feline alternating the food composition described herein and another corresponding food composition.
[0241] A food composition described herein for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, can be formulated in such a manner that the body weight of the feline is not significantly affected.
[0242] In some embodiments, a method for treating and / or preventing feline atopic dermatitis in feline in need thereof can further include a step of making a feeding recommendation that includes a food composition described herein.
[0243] An object of the present disclosure relates to a method for feeding a feline wherein the method includes at least a step of administering a food composition according to the present disclosure to the feline. In some particular embodiments, the feline suffers from feline atopic dermatitis.
[0244] The present disclosure also relates to a method of manufacturing a food composition for a feline described herein including at least a step of mixing all the ingredients together.
[0245] The food composition described herein can be prepared according to the techniques which are well known to a person skilled in the art.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0246] The food composition can be made according to any method known in the art such as in Waltham Book of Dog and Cat Nutrition, Ed. ATB Edney, Chapter by A. Rainbird, entitled 'A Balanced Diet" in pages 57 to 74 Pergamon Press Oxford. For instance, a process for the manufacture of a food composition described herein can include mixing together ingredients having a source of EPA and DHA, optionally a source of curcuminoids. Heating and cooking can be applied to any one or more of the ingredients prior to, during or following the mixing.
[0247] This disclosure can be further illustrated by the following examples of embodiments thereof, although it will be understood that these examples are included merely for purposes of illustration and are not intended to limit the scope of the disclosure.EXAMPLESIndexBW : Body weightDHA: Docosahexaenoic acidEPA: Eicosapentaenoic acidFeDESI: Feline Dermatitis Extent and Severity IndexVAScat: Visual Analog Scale for feline pruritus severity scoringEXAMPLE 1: Evaluation of the efficacy of a food composition described herein on FASS
[0248] In this study, it was investigated the potential of a food composition to improve the effect of conventional drug-based strategies for treating FASS. The food composition tested includes Omega-3 Polyunsaturated Fatty Acids (PUFAs) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), as well as a phytochemical extract from turmeric root.A. MATERIAL AND METHODS
[0249] The assay was double-blinded and placebo-controlled. Twenty-five (25) adult cats, diagnosed with Feline Atopic Skin Dermatitis (FASS) based on guidelines by Santoro et al. (2021), were randomly allocated to one of two groups: test food or control food (Table 1).
[0250] The diets were given code names and packaged in identical bags. Both test and control diets were dry kibble format, and nutritionally complete and balanced for adult cats (95kcal / kgA0.75 NRC 2006). Ingredients were standard pet food materials, except for turmeric extract from Indena® (Bengaluru, India), the turmericAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 extract containing 20% by weight of curcuminoids. The test diet's omega-6 linoleic acid content was increased by replacing pork fat with soya oil and chicken fat. Omega-3 fatty acids were supplemented primarily via marine algal oil, with a small minority (~5%) from fish oil. Owners were instructed to feed the provided diets exclusively and transition gradually over six days.Table 1. Key nutritional information for the two diets fed during the study.Dietcomponent Units Test ControlDry matter g / Mcal 270 271Moisture % 5.2 5.3Protein g / Mcal 95.7 95.3Fat g / Mcal 62.9 64.3Ash g / Mcal 19.1 18.9Total Fiber g / Mcal 27.7 28.9Linoleic acid g / Mcal 11.4 7.5EPA+DHA g / Mcal 1.43 0.09EPA / DHA g / Mcal 0.51 / 0.92 0.03 / 0.06Vitamin E g / Mcal 0.29 0.14Vitamin C g / Mcal 0.1 0.087Taurine g / Mcal 1.17 0.68Lutein g / Mcal 0.0034 0.0024Curcuminoids g / Mcal 0.41 0Initial Clinical Scoring
[0251] Veterinary dermatologists performed all evaluations. Cats were assessed for skin lesions and pruritus using FeDESI and VAScat scores. Medications used during the month prior to inclusion were recorded, and a medication score was derived according to the system shown in Table 2. Monthly treatments were recorded, with drug, dosage, and frequency attributed a numerical score. The overall score for each month was determined by summing daily scores and dividing by the number of days in the month.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1Table 2: Medication Score determination scheme; based on Saridomichelakis et al.Medication / Treat merit Dose / schedule Daily scoreNo concurrent medication 0 Prednisolone / Dexamethasone >lmg / kg / d 400.5-lmg / kg / d 300.2-0.5mg / kg / d 20<0.2mg / kg / d 10Atopica (5mg / kg bwt) daily 30every other day 20every third day 10every fourth day 5Apoquel twice daily 40daily 30every other day 20every third day 10Anti-histamine 10 Antibiotics (>21 days) 20 Antibiotics (<21 days) 10 Topical steroids 5 Topical hydrocortisone 5 Shampoo 5 Ear wash 5Ear drops 5Follow-up Consultations
[0252] Follow-up consultations were scheduled once every month during six months after diet initiation. Telephone consultations were conducted at months 1 , 2, 4, and 5, focusing on pruritus (VAScat) and medication scores. In-person evaluations at months 3 and 6 included a full physical exam and recording of FeDESI, VAScat, and medication scores.
[0253] Owners reported food consumption and evaluated stool quality using a five-point scale (5=hard to 1 =liquid diarrhea; optimal = 2.5).
[0254] At inclusion the mean FeDESI scores for the two groups were Test, 19 (4-46) and Control, 26 (6-60), with no significant difference between the groups (p=0.23). Average VAScat at initiation was 7.3 (6-10) in the Test group and 5.5 (3-8) in the Control group, with no significant difference between the two (p=0.085). Average Medication scores were Test, 28 (5-70) and Control, 27.5 (5-45), with no difference between the two (p=0.94).Outcome MeasuresAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0255] Drop-out reasons and unexpected events were recorded. Primary measures included FeDESI, VAScat, and Medication scores. The percentages of cats with >50% improvement in clinical scores were computed for both groups. Additionally, the number of cats returning to normal / remission (FeDESI<11) was recorded.Statistical Methods
[0256] Statistical analyses were performed using R Core Team. Linear mixed models evaluated the impact of Diet, Time, and Time by Diet interaction on FeDESI, VAScat, and Medication scores, with the animal modeled as a random term. Statistical assumptions were verified using the Shapiro-Wilk test for normal distribution of residuals and graphically for homoscedasticity. Tukey HSD was used for post-hoc comparisons. The significance level was set at 5%. Median (m in-max) values are provided. Analyses included all cats that received the study diet per protocol, except those lost to follow-up before month 2. Adverse events are reported for enrolled cats receiving the study diet.B. ResultsDigestibility
[0257] Digestibility of the diets was assessed throughout using the faecal scoring system. The results indicated that the diet was well tolerated in both the test and control groups.Evolution of clinical scores
[0258] There was a significant effect of time on FeDESI (p = 0.0047), VAScat (p <0.0001) and Medication scores (p <0.0001). There was a significant interaction between diet and time point for VAScat (p = 0.012) and Medication score (p = 0.004).
[0259] FeDESI, VAScat and Medication score were compared within each diet between baseline and months 3 and 6 as well as between the two diet groups at each timepoint (Figures 1a-c; Tables 4 and 5).
[0260] In the Test diet group, FeDESI decreased significantly between baseline and 3 months (p=0.037) and 6 months (p=0.02), but not in the Control group (Figure 1 ). At 3 months the effect size was greater for the Test group (1.01 (0.19-1.83)) than the Control group (0.46 (0.57-1.48), whereas at 6 months the effect sizes were similar (Test 1.33 (0.34-2.32) vs Control 1.42 (0.06-2.78)). No difference between groups was observed when comparing Test and Control for the 3 and 6-month timepoints (P=0.6 and 0.09 respectively).Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1
[0261] In the Test group, the VAS-cat owner pruritus assessment showed a significant decrease between baseline and both 3 months (p<0.0002) and 6 months (p<0.0001), whereas no difference was seen in the Control group (Figure 2). Effect sizes were higher in the Test group at both 3 and 6 months, 1.71 (0.88-2.53) and 2.03 (1.1-3) respectively, versus the Control group, 0.2 (-0.76-1.16) and 0.32 (-0.77-1.41). There was no difference between diet groups at 3 and 6-months (p=0.91 and p=0.82 respectively).
[0262] The Medication scores reveal the monthly status of disease status via the proxy of medication requirement for effective symptom treatment or reduction of the seventy. When the monthly scores are compared to baseline, it is observed a clear difference in medication used between the two groups. There is a consistent, significant reduction in the average medication requirement relative to baseline for the cats fed the Test diet. This is observed as early as the 2-month timepoint (p<0.02) and is maintained for all subsequent timepoints until the end of the study (Figure 3). In contrast, for the Control group, there is no change observed in the average Medication score at any timepoint relative to baseline. What is more, effect sizes were consistently higher for the Test group than the Control group (range 1.15-2.14 vs range -0.41-1.02 respectively). When the two diet groups are compared for each timepoint, there is a significant difference between the 2 groups at month 6. At this timepoint the Test diet fed cats required significantly less medication than the Control group.Clinical improvement summary
[0263] A summary of the clinical improvement outcomes for both groups is presented in Table 3.Table 3. Percentage of cats showing a minimum 50% improvement in Lesion severity (FeDESI), Pruritus intensity (VAS-cat) and Medication Score after defined intervals of feeding the Test or Control diet.Diet Test Control Timepoint (months) 2 3 4 5 6 2 3 4 5 6 FeDESI 47% 50% 30% 67% VAS-cat 40% 45% 10% 14% Medication score 20% 53% 57% 69% 73% 20% 20% 50% 29% 17%Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 - FeDESI score
[0264] In the Test group, approximately 50% of cats showed an improvement of at least 50% in their FeDESI score at both 3 and 6 months.
[0265] In the Control group, 30% of cats had improved 50% or more in their FeDESI score at 3 months, increasing to 67% at 6 months.
[0266] VAScat score
[0267] In the Test group, a reduction of more than 50% in VAScat score was observed in 40% of cats at 3 months, rising slightly to 45% at 6 months.
[0268] In the Control group, only 10% of cats showed a similar improvement at 3 months, increasing slightly to 14% by 6 months.
[0269] Medication scores
[0270] At 2 months, a minimum of 50% reduction in MS is observed in 20% of cats for both groups.
[0271] At 3 months, 50% MS reduction was observed in 57% of Test cats, but remained at 20% for Control cats.
[0272] At 6 months, 73% of Test group cats showed a minimum 50% MS reduction, compared to only 17% in the Control group.
[0273]
[0274] Finally, when considering the number of cats in each group that achieved remission (remission defined here as a FeDESI score <11 ), this was seen in 80% of Test cats by 3 months and remained at 80% when reaching 6 months.
[0275] In the Control group, 40% of cats achieved remission by 3 months and 50% at 6 months.C. CONCLUSION
[0276] The present assay demonstrated that the food composition described herein, enriched with a specific ration of DHA and EPA and turmeric extract, significantly improved clinical outcomes in cats diagnosed with Feline Atopic Skin Dermatitis (FASS) compared to the control diet.
[0277] Cats fed the test diet exhibited notable reductions in FeDESI, VAScat, and Medication scores over the six-month period, indicating enhanced reduction of skin lesions and pruritus, as well as a decreased reliance on medication. Specifically, the test diet group showed a higher percentage of cats achieving a minimum 50% improvement in clinical scores and a greater number of cats reaching remission (FeDESI <11 ) by the end of the study, suggesting that the test food composition canAttorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 effectively support the return to normal skin health. These findings suggest that the inclusion of specific nutritional components in the diet can effectively complement conventional drug-based treatments for FASS, offering a promising strategy for improving the quality of life in affected cats.
Claims
Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 CLAIMS1. A food composition comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), for use in a method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, whereinthe mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3: 1 to about 0.9: 1 , andthe total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal.
2. The food composition for use according to claim 1, wherein the food composition comprises from about 0.1 g / Mcal to about 2 g / Mcal of curcuminoids.
3. The food composition for use according to claim 2, wherein the curcuminoids are selected from curcumin, demethoxycurcumin, bisdemethoxycurcumin and / or tetrahydrocurcumin.
4. The food composition for use according to any one of claims 1 to 3, wherein the food composition comprises from about 0.05 g / Mcal to about 10 g / Mcal of EPA.
5. The food composition for use according to any one of claims 1 to 4, wherein the food composition comprises from about 0.05 g / Mcal to about 20 g / Mcal of DHA.
6. The food composition for use according to any one of claims 1 to 5, wherein the food composition comprises a total amount from about 0.5 g / Mcal to about 10 g / Mcal of EPA and DHA.
7. The food composition for use according to any one of claims 1 to 6, wherein a source of EPA and DHA is selected from fish oil, fish meal, algae oil, eggs, oyster, chia seed, walnuts, soybeans, Green Leaped Mussel or a mixture thereof.
8. The food composition for use according to claim 7, wherein a source of EPA and DHA substantially consists of algae oil.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 9. The food composition for use according to claim 8, wherein algae oil provides at least about 80% of the total EPA and DHA content in the food composition.
10. The food composition for use according to any one of claims 1 to 9, wherein the composition further comprises linoleic acid, Taurine, Lutein, Vitamin E, or combinations thereof.
11. The food composition for use according to any one of claims 1 to 10, wherein the composition further comprises at least one of:- from about 4.5 g / Mcal to about 23 g / Mcal of linoleic acid;- from about 0.2 g / Mcal to about 5 g / Mcal of Taurine;- from about 0.002 g / Mcal to about 0.015 g / Mcal of Lutein;- from about 0.1 g / Mcal to about 1.5 g / Mcal of Vitamin E;or combinations thereof.
12. The food composition for use according to any one of claims 1 to 11, wherein the food composition does not comprise glycyrrhizin.
13. The food composition for use according to any one of claims 1 to 12, wherein the food composition is a nutritionally complete and balanced food composition.
14. The food composition for use according to any one of claims 1 to 13, wherein the feline atopic dermatitis is an environmental allergen-induced atopic dermatitis.
15. The food composition for use according to any one of the preceding claims, wherein the feline atopic dermatitis is a feline atopic skin syndrome.
16. The food composition for use according to any one of the preceding claims, wherein the food composition is provided to the feline during, before and / or after a treatment with an anti-feline atopic dermatitis agent, optionally for a period of between about one month to about thirty-six months.Attorney Docket No.: 000307-0228-00304Mars Ref.: MARS / P / 394302 / WO / SEC / 1 17. The food composition for use according to any one of the preceding claims, wherein the feline is a cat.
18. A method for treating and / or preventing feline atopic dermatitis in a feline in need thereof, the method comprising at least a step of providing a food composition, comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), to the feline,whereinthe mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3: 1 to about 0.9: 1 , andthe total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal.
19. Use of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in the manufacture of a food composition for managing, treating and / or preventing feline atopic dermatitis in a feline in need thereof,whereinthe mass ratio of EPA to DHA is from about 0.2:1 to about 1:1, preferably from about 0.3: 1 to about 0.9: 1 , andthe total amount of EPA and DHA is from about 0.1 g / Mcal to about 20 g / Mcal.
